Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05WEF
|
||||
Former ID |
DNC013217
|
||||
Drug Name |
N-benzyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528709] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H13N3O4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=C2C=C(C=C3)[N+](=O)[O-<br />]
|
||||
InChI |
1S/C17H13N3O4/c21-16(17(22)19-9-11-4-2-1-3-5-11)14-10-18-15-7-6-12(20(23)24)8-13(14)15/h1-8,10,18H,9H2,(H,19,22)
|
||||
InChIKey |
JYXHNHBKWZQGLB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [528709] | |
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [528709] | ||
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [528709] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.